Christopher Seidel - Concepedia

Author

Christopher Seidel

Also Known As

Christopher P. Seidel, Christopher Seidel

Publications

465

Citations

H-Index

Concepts

All Affiliations

Christopher Seidel is an author at Johns Hopkins Medicine specializing in ophthalmology, medicine, and vascular biology.

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	464
2	Health Sciences	3	3	141
3	Immunology	2	2	247
4	Cell Biology	1	1	218
5	Diabetes	1	1	63

Christopher Seidel

Publications

464

Citations

H-Index

Page 1

	Year	Citations
Targeting VE-PTP activates TIE2 and stabilizes the ocular vasculature Jikui Shen, Maike Frye, Bonnie L. Lee, Journal of Clinical Investigation InflammationRetinal VesselsOcular DiseaseSignal TransductionAngiogenesis	2014	218
Sustained delivery of a HIF-1 antagonist for ocular neovascularization Takeshi Iwase, Jie Fu, Tsunehiko Yoshida, Journal of Controlled Release Ocular DiseaseOphthalmologyMedicineVascular BiologyPharmacotherapy	2013	76
Antagonism of PDGF-BB suppresses subretinal neovascularization and enhances the effects of blocking VEGF-A Aling Dong, Christopher Seidel, Daniel Snell, Angiogenesis AngiogenesisOphthalmologyMicrovascular DysfunctionVascular BiologyNeovascularization	2013	68
Suppression of GLUT1; A new strategy to prevent diabetic complications Lili Lu, Christopher Seidel, Takeshi Iwase, Journal of Cellular Physiology Ocular DiseaseRetinal TherapiesInsulin SignalingMetabolic SyndromeDiabetic Retinopathy	2012	63
Agents that bind annexin A2 suppress ocular neovascularization Raquel Lima e Silva, Jikui Shen, Yuan Gong, Journal of Cellular Physiology Translational MedicineOcular DiseaseOphthalmologyExperimental OphthalmologyMedicine	2010	29
The Nicotinic Cholinergic Pathway Contributes to Retinal Neovascularization in a Mouse Model of Retinopathy of Prematurity Sean F. Hackett, Christopher Seidel, Sheena Abraham, Investigative Ophthalmology & Visual Science Ocular DiseaseNachr SubunitsRetinal NeovascularizationOptogeneticsMolecular Pharmacology	2017	10

Page 1